Table 4 Multivariate analysis for predictors of recurrence involving hormone therapy in ER(+) and/or PR(+) patients
From: Young age: an independent risk factor for disease-free survival in women with operable breast cancer
Variables | HR | 95% Confidence interval | p |
|---|---|---|---|
Age <35 years | 2.1 | 1.14–4.20 | 0.018 |
Tumor size ≥ 2 cm | 2.2 | 1.39–3.62 | 0.001 |
Lymph node-positive | 3.3 | 1.81–6.14 | <0.001 |
Nuclear grade 3 | 1.0 | 0.45–2.31 | 0.961 |
Histological grade 3 | 1.2 | 0.55–2.85 | 0.576 |
Hormone therapy (yes) | 1.6 | 0.93–2.77 | 0.086 |
c-erbB2 | 1.4 | 0.81–2.42 | 0.228 |